Related Experiment Video
Updated: Apr 20, 2026

10:03
Screening for Amyloid Aggregation by Semi-Denaturing Detergent-Agarose Gel Electrophoresis
Published on: July 16, 2008
28.8K
Protein microgels from amyloid fibril networks
Ulyana Shimanovich1, Igor Efimov, Thomas O Mason
1Department of Chemistry, University of Cambridge , Lensfield Road, Cambridge CB2 1EW, U.K.
ACS Nano
|December 4, 2014
Summary
Protein nanofibrils form biocompatible microgels for controlled drug delivery. These novel materials show potential for enhanced antibiotic efficacy and in situ network modulation.
Area of Science:
- Biomaterials Science
- Nanotechnology
- Protein Engineering
Background:
- Protein nanofibrils, initially linked to pathology, are now recognized for diverse natural functions.
- These include roles as catalytic scaffolds and bacterial coatings, highlighting their versatility.
Purpose of the Study:
- To investigate the use of protein nanofibrils for creating functional microgels and gel shells.
- To explore the potential of these protein microgels as drug delivery agents.
- To demonstrate the controlled release of encapsulated molecules and the in situ modulation of material properties.
Main Methods:
- Fabrication of monodisperse microgels and gel shells using naturally occurring protein nanofibrils.
- Encapsulation and controlled release studies of small molecules and proteins.
- Assessment of in situ network density modulation via continued protein nanofibril self-assembly.
- Evaluation of material cytotoxicity to human cells and impact on antibiotic efficacy.
Main Results:
- Successfully formed monodisperse protein microgels and gel shells from naturally occurring proteins.
- Demonstrated controlled release of four drug-like small molecules and component proteins.
- Showcased in situ modulation of network density through continued self-assembly.
- Confirmed non-toxicity to human cells and enhanced antibiotic efficacy compared to solution delivery.
Conclusions:
- Protein nanofibril microgels are a promising class of functional artificial multiscale materials.
- Their biocompatibility, biodegradability, and controlled release capabilities make them ideal for drug delivery.
- These materials offer tunable properties and enhanced therapeutic potential, derived from natural building blocks.
More Related Videos
Related Concept Videos
Amyloid Fibrils
13.2K
Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
13.2K
Amyloid Fibrils
7.0K
7.0K

